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Cryosurgery employs freezing to destroy solid tumours. However, frozen cells can survive and cause cancer recurrence.
Bleomycin, an anticancer drug with a huge intrinsic cytotoxicity is normally not very effective because it is nonpermeant. We
report that freezing facilitates bleomycin penetration into cells making it toxic to cryosurgery surviving cells at concentrations
that are non-toxic systemically.
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Cryosurgery is a minimally invasive surgical technique that
employs freezing to destroy solid tumours. Deep in the body it
is performed with needle-like cryogen cooled probes, inserted in
the tumour. The extent of freezing is controlled by imaging (Onik
et al, 1984, 1991; Rubinsky, 2000). The frozen tissue is left to thaw
in situ and is disposed by the body immune system. During cryo-
surgery, freezing propagates from the cryosurgical probe outward.
Cells in the frozen lesion experience a range of temperatures from
cryogenic near the probe interface (lower than 71408C), to phase
transformation on the outer edge (70.568C) (Rubinsky, 2000). On
the outer rim of the frozen lesion, in the temperature range
between 70.568C and about 7408C, cells can survive (Rui et al,
1999; Rubinsky, 2000). Therefore, despite imaging, there is uncer-
tainty in the application of the procedure and at times cryosurgery
failure (Revoire et al, 1996).
Bleomycin is an anticancer drug with a huge intrinsic cytotoxi-
city. It is not very effective because it cannot enter cells freely (Mir
et al, 1996; Pron et al, 1999). However, increasing cell membrane
permeability with electrical procedures results in a huge increase
in bleomycin cytotoxicity, (Belehradek et al, 1993; Mir et al,
1998; Kotnik et al, 2000; Mir, 2001). Our hypothesis was that
the change in membrane permeability and increase in extracellular
solute concentration during freezing (Mazur, 1970; Rubinsky,
2000) might facilitate penetration of bleomycin in frozen cells
which could make it useful in treating cells on the outer rim of
the frozen lesion. We tested the hypothesis by freezing cells with
thermal parameters typical to the outer rim of the frozen lesion,
in which cells survive freezing, in the presence of various doses
of bleomycin (Rui et al, 1999; Rubinsky, 2000). This found that
freezing facilitates bleomycin penetration into cells, making it toxic
to cryosurgery surviving cells at concentrations that are normally
non-toxic. Since both cryosurgery and bleomycin are routinely
used for clinical treatment of cancer the combination should have
immediate clinical utility.
MATERIALS AND METHODS
Experiments were performed with B16 F0 melanoma cells (ATCC
CRL 6322). First, 100 ml of S-MEM (Life Technologies, Rockville,
MD, USA) in a 15 ml tube (Falcon, Becton Dickinson, Franklin
Lakes, NJ, USA) were frozen in a 7208C freezer, in air, to produce
an ice seed. Then 400 ml of cells just suspended in ice-cooled S-
MEM with either 5 mM, 500 nm, 100 nm or 10 nm of bleomycin
or without bleomycin were put in the test tubes with the frozen
solution and inserted in the 7208C freezer. A T type thermocouple
(Omega, Stamford, CT, USA) which was put in a thermal control
sample and used with each experiment has shown that the solu-
tions froze with a cooling rate of 1+0.28C/min to a temperature
of 714+18C. The cells were exposed to freezing conditions for
30+4 min. The frozen samples were thawed by immersion in
water at room temperature. They thawed within 10 min. Following
thawing the samples were diluted with 2 ml of normal MEM
culture medium (Life Technologies) supplemented with 8% foetal
calf serum (Life Technologies) and penicillin and streptomycin
(Sarbach/Solvay Pharma, Brussels, Belgium), which resulted in a
ﬁve times dilution of the bleomycin concentration. Cells were
transferred to 35 mm Petri dishes (TPP, Trasadingen, Switzerland)
and incubated at 378C and 5% CO2 (Universal Water Jacketed
Incubator, Forma Scientiﬁc, Marietta, OH, USA). Overall viability
of the cells was inspected visually immediately after and 3 to 4 h
after the treatment. Six hours after the treatment (i.e. after cell
attachment), medium was changed in the experiments in which
cells were exposed to 5 mM bleomycin in order to reduce the exter-
nal concentration of the drug to non-cytotoxic levels. In the case of
the experiments with 500 nM, 100 nM or 10 nM bleomycin, the
medium was only changed 24 h after the treatment (it has been
shown that for all these concentrations a ﬁve times dilution is
below the toxic concentration when cell exposure time to bleomy-
cin or bleomycin analogues was 48 h or longer (Takahashi et al,
1987)). In half of the controls the medium was also changed after
6 h and in the other half after 24 h, to remove the cells killed by
the freezing procedure. No statistical difference in the number of
colonies was observed between these two groups of controls. After
137 h of culture the medium was removed, cells were ﬁxed using
1.5 ml of formol 2% in NaCl 0.9% for 10 min, and then stained
for 15 min using 2 ml of crystal violet (Labo Moderne, Paris,
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www.bjcancer.comFrance) diluted to 1:5 in water. After extensive rinsing, colonies
were manually counted under a binocular microscope Stemi SV6
(Zeiss, Le Pecq, France). Photographs were taken using a Contax
167MT camera (Zeiss) directly installed on an Axiovert 135 (Zeiss)
inverted microscope, on 160 T Ektachrome Kodak ﬁlms. Slides
were scanned using a Mirage S2 scanner (UMAX). Statistical analy-
sis was performed using ANOVA (One Way Analysis of Variance).
RESULTS AND DISCUSSION
The apparent cell survival immediately after thawing, evaluated
from cell membrane integrity and morphology, was low, typical
to the tested freezing conditions and relatively similar in all the
samples with no discernable trend. This is to be expected as the
effect of bleomycin should be long term, to prevent cell division,
and not immediately evident. Table 1 compares the long-term
survival of B16 F0 melanoma cells, in culture. Six experiments with
cells frozen in S-MEM alone show that they produced a mean of
242+153 colonies. In contrast, bleomycin at concentrations of
5 mM, 500 nm and 100 nm caused, in four separate experiments
for each concentration, a signiﬁcant decrease in viability producing
a mean of 1+2, 0, and 0.5+0.6 colonies, respectively (statistically
different of the controls, P50.001 using ANOVA test). The effect
of bleomycin seems to taper off at a concentration of 10 nm, for
which four experiments produced a mean of 13+8.2 colonies
(statistically different of the three other bleomycin groups,
P=0.002 using ANOVA test).
It is well established in the cryobiology literature that cells can
survive freezing. There are various mechanisms of freezing damage
and they are complex. On the outer edge of the frozen cryosurgical
lesion, where cells survive, the mechanism of damage is due to
‘low’ cooling rates (Rubinsky and Shitzer, 1976; Rubinsky, 2000).
Mazur (1970) explained that at what are considered ‘low’ cooling
rates, ice forms ﬁrst extracellularly, while the intracellular solution
does not freeze and remains supercooled. Ice has a tight crystallo-
graphic structure and rejects the solutes in the unfrozen region,
usually around the unfrozen cells. To equilibrate the difference in
chemical potential across the cell membrane water leaves the cell
to freeze in the extracellular space. The consequent cell dehydration
causes an increase in intracellular cell osmolality. Cell dehydration
together with cell membrane lipid phase transition and transmem-
brane ionic leakage combine to produce chemical damage to
intracellular components. The range of temperatures in which the
chemical damage takes place is between the phase transition
temperature, 70.568C, and the saline eutectic, about 7328C.
While the mechanism of damage is the same in the entire tempera-
ture range, the extent of the damage increases with lower
temperatures and with time of exposure. The thermal parameters
employed in this study were chosen because they are typical of
non-lethal freezing thermal parameters most relevant to the
problems of cryosurgery. The cooling rate of 18C/min is typical
to ‘low’ cooling rates (Rubinsky and Shitzer, 1976, 2000), the
temperature of 7148C is a typical temperature in which cell survi-
val was observed and in which the mechanism of damage is
chemical (Revoire et al, 1996; Rui et al, 1999; Rubinsky, 2000)
and the time of exposure of 30 min is typical to how long a cryo-
surgical procedure takes (Onik et al, 1984, 1991).
Table 1 demonstrates that bleomycin has the ability to signiﬁ-
cantly increase cell damage at thermal conditions typical to those
on the outer rim of a cryosurgical lesion. Bleomycin molecules
form complexes with Fe
2+ and O2 that directly generate breaks
on DNA through the nucleophilic attack of the C'4 of the deso-
xyribose, particularly at the GC sequences (Povirk et al, 1989;
Mir et al, 1996). Since bleomycin must penetrate the cell to affect
cell survival, the data presented in Table 1 suggests that the bleo-
mycin has entered the cells during freezing and that it is affecting
cells which otherwise would have survived the freezing protocol.
Figure 1 conﬁrms this. It shows the appearance of cells grown
after freezing with and without bleomycin, after 137 h of culture.
The cells that survived the freezing procedure and were not
exposed to bleomycin attached to the substrate and kept normal
morphology as well as growth features (Figure 1A). On the
contrary, in the presence of bleomycin at the time of cell freezing,
the attached cells did not show mitoses and their morphology was
very altered (Figure 1B). Moreover, these ﬁgures show ‘mitotic
cell death’ typical of bleomycin internalisation (Tounekti et al,
1993, 2001).
While an anticancer drug with a huge intrinsic cytotoxicity
(several hundred molecules of bleomycin inside the cell are sufﬁ-
cient to kill (Poddevin et al, 1991), mediated by the generation
of DNA double-strand breaks), bleomycin is normally not very
effective for treatment of cancer because it is nonpermeant (it
enters cells not by diffusion through the plasma membrane
(Poddevin et al, 1991) but rather by a mechanism of receptor-
mediated endocytosis) (Mir et al, 1996; Pron et al, 1999). There
is abundant evidence to show that concentrations of 500 nm and
100 nm bleomycin have no effect on cells (Barranco and
Humphrey, 1971; Takahashi et al, 1987; Mir et al, 1996). This
study demonstrates that bleomycin at doses as low as 100 nm,
and even 10 nm, has the ability to signiﬁcantly reduce the survi-
val of cells frozen with thermal conditions typical of the outer
rim of the cryosurgical frozen lesion. For the bleomycin to func-
tion at these low concentrations there must be a mechanism by
which it can enter the cells during freezing. It is established that
the cell membrane is permeabilised during cooling and freezing
due to such mechanisms as lipid phase transition, dehydration
induced membrane deformation and ice crystal induced
membrane deformation (Mazur, 1970; Quinn, 1985). In addition,
as discussed earlier, because ice cannot contain solutes, the effect
of freezing is to reject all the solutes in the unfrozen region,
around the cells. This usually increases the ionic concentration
around the cell; however, when bleomycin is present in the solu-
tion the concentration of bleomycin near the cell will also
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Table 1 Comparison of the survival of B16 F0 melanoma cells that were
frozen in the absence or in the presence of either 5 mM, 500 nM, 100 nM or
10 nM of bleomycin
Freezing with bleomycin Freezing without bleomycin
Dose Number of clones Number of clones
5 mM 0 507
5 mM 4 232
5 mM 05 9
5 mM 0 304
170
182
Mean: 1+2 Mean: 242+153
500 nM 0
500 nM 0
500 nM 0
500 nM 0
Mean: 0
100 nM 0
100 nM 1
100 nM 0
100 nM 1
Mean: 0.5+0.6
10 nM 11
10 nM 25
10 nM 7
10 nM 9
Mean: 13+8.2
Viability was determined by the measurement of the cloning efﬁciency of the cells
surviving to the freezing.
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membrane permeability during cooling and freezing, as well as
the freezing-induced increase in bleomycin concentration around
cells will cause the bleomycin to enter cells during cryosurgery,
when used at doses that otherwise would have no effect on
the cells.
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Figure 1 Typical morphological differences between B16 F0 melanoma cells that were frozen in the absence (A) or in the presence of 100 nm of bleo-
mycin (B), after 137 h of incubation. (Magniﬁcation 11006). In the absence of bleomycin, the surviving cells display a normal morphology, regular cell size,
and the usual nucleus aspect. Normal mitosis can be observed in the two rounded cells on the right upper part of panel A. In contrast, in panel B cells show
abnormal morphology. The size of the nuclei and cytoplasm has increased. The limits of the nucleus are not always demarcated while the cytoplasm itselfi s
clear. Among cells there are large differences in nuclei and cell size.
Cryochemotherapy
LM Mir and B Rubinsky
1660
British Journal of Cancer (2002) 86(10), 1658–1660 ã 2002 Cancer Research UK